Ceramide/Sphingosine-1-phosphate in patients with Hypertension Compared with normotensive controls: a case-control Study

Completed

• Conditions: Bloeddrukregulatie; Hypertension en verhoogde bloeddruk; 10013317

• Registration Number: NL-OMON40437
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

Patients with age between 18 and 55 years with Grade 1 to 3 Hypertension

Exclusion Criteria

Pregnancy
Use of statin medication
Age under 18 years

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main study parameter is the subfraction of<br /><br>Ceramide/Sphingolipid-1-phosphate in serum plasma </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not Applicable</p><br>